Nu Skin Enterprises, Inc. has announced record fourth-quarter results with revenue of $588.2 million, up 19% over the prior-year period, owing in large part to its wildly popular anti aging ageLOC products in key Asian markets. Revenue was not materially impacted by foreign currency fluctuations. Earnings per share for the quarter were $0.97, a 27% year-over-year improvement. The company also announced that it is increasing its full-year 2013 revenue guidance by $50 million to $2.30 to $2.35 billion. The company expects 2013 earnings per share to be in the range of $3.77 to $3.92 with an anticipated negative foreign currency impact of 3-4%.
The company reported full year 2012 revenue of $2.17 billion, a 24% year-over-year improvement. Annual revenue was negatively impacted 1% by foreign currency fluctuations. Earnings per share for the year were $3.52, a 48% increase over 2011, or 31% when excluding charges related to a Japan customs case in the prior year.
"We are pleased with our solid fourth-quarter results and believe 2013 will be another record year as we launch a new wave of compelling anti-aging products and project strong performances around the world," said Truman Hunt, president and chief executive officer. "Our growth in the fourth quarter was driven by particularly strong trends in several key markets including Japan, South Korea and Mainland China where we continue to see tremendous results from our latest ageLOC products. We expect the upcoming launch of our ageLOC weight-management system to drive significant growth in the back-half of the year."